The International 14th Puijo Symposium:

“Physical Activity, Diet and Cardiovascular Diseases - A Fresh Look Beyond Old Facts”

 

Scientific Program


 

June 25, 1996

 

PREVENTION OF CARDIOVASCULAR DISEASES

Clinical  Trials on Physical Exercise and CHD Risk Factors Current State of the Artó, Dr Arthur S. Leon, USA

Scientific Basis for Medical Prescription of Physical Exercise, Dr William L. Haskell, USA

Diet and Coronary Heart Disease - the Finnish Experiences, Dr Antti Aro, Finland

 

NEW INSIGHTS INTO PREVENTION OF CARDIOVASCULAR DISEASES

Pathophysiology and Genetics of Insulin Resistance Syndrome, Dr Markku Laakso, Finland

Epidemiology of Insulin Resistance Syndrome, Dr Markolf Hanefeld, Germany

Physical Activity, Muscular Metabolism and the Insulin Resistance Syndrome, Dr Angelo Tremblay, Canada

Visceral Obesity as a Component of the Insulin Resistance Dyslipidemic Syndrome: Effect of Physical Activity, Dr Claude Bouchard, Canada

Early Intervention in NIDDM and Impaired Glucose Tolerance, Dr Matti Uusitupa, Finland


 

June 26, 1996

 

LIPOPROTEIN METABOLISM AND ATHEROGENESIS

Gender Differences in Coronary Heart Disease: Why Are Women So Superior? Dr Elizabeth  Barrett-Connor, USA

LDL-Particle Size in Atherogenesis, Dr Manfred Baumstark, Germany

Lessons from HDL-Deficiency for Reverse Cholesterol Transport, Dr Arnold von Eckardstein, Germany

Lipoprotein(a) and Atherogenesis, Dr Christian Enholm, Finland

Molecular Mechanisms of Reverse Cholesterol Transport, Dr Matti Jauhiainen, Finland

Remnants, apoE and atherosclerosis, Dr Jean Davignon, Canada

Physical Activity and Lipoprotein Metabolism: Epidemiological Evidence and Clinical Trials, Dr Aloys Berg, Germany

Diet and Lipoprotein Metabolism: Epidemiological Evidence and Clinical Trials, Dr Antero Kesäniemi, Finland   

Future Directions in Research: Physical Activity, Diet and Lipoprotein Metabolism, Dr Steven N. Blair, USA


 

June 27, 1996

 

THROMBOGENESIS IN CARDIOVASCURAL DISEASES

Role of Thrombosis and Fibrinolysis in CHD, Dr Tom Meade, UK

Physical Activity and Thrombogenesis: Epidemiological Observations and Clinical Trials, Dr Tuomo Rankinen, Finland

Diet and Thrombogenesis: Epidemiological Observations and  Clinical Trials, Dr George Miller, UK

Gene-Environment Interaction in the Determination of Plasma Levels of Fibrinogen and Factor V, Dr Fiona Green, UK

Gene-Environment Interactions Determining Fibrinolytic Function, Dr Anders Hamsten, Sweden

Future Directions in Research: Physical Activity and Thrombogenesis, Dr Rainer Rauramaa, Finland


 

June 28, 1996

 

MOLECULAR BIOLOGY

Gene Therapy for Atherosclerosis, Dr Marja Laitinen, Finland

Gene-Physical Activity and Gene-Diet Interactions: from Genetic Epidemiology to Molecular Markers, Dr  Claude Bouchard, Canada

Fit for Life – National Health Program in Finland, Dr Timo Haukilahti, Finland